Azitra Inc
$0.17
Market Cap
$10.55M
Shares Outstanding
60.6M
Primary Exchange
XASE
Currency
USD
Type
CS
IPO Date
Jun 16, 2023
Round Lot
100
Locale
US
Day Open
$0.18
Day High
$0.18
Day Low
$0.17
Volume
1.12M
VWAP
$0.17
Prev Close
$0.18
Transactions
--
Acc. Volume
--
Azitra Inc is an early-stage clinical biopharmaceutical company focused on developing therapies for precision dermatology using engineered proteins and live biotherapeutic products. Its discovery platform is screened for naturally occurring bacterial cells with beneficial effects. These microbes are then genomically sequenced and engineered to make cellular therapies, recombinant therapeutic proteins, peptides, and small molecules for the precision treatment of dermatology diseases. The company's product candidates include ATR-12, for treating the orphan disease and Netherton syndrome; ATR-04, a genetically modified strain of S. epidermidis for treating the papulopustular rash; and ATR-01, a potential treatment for ichthyosis vulgaris, a chronic, abnormally dry, scaly skin disease.
Azitra Inc (AZTR) closed the 2026-09-18 session at $0.17, down 2.25% versus the previous close (-0.00). The stock opened at $0.18 and traded between $0.17 and $0.18 during that session. Session trading volume was 1.1M shares. The volume-weighted average price (VWAP) is $0.17.
Azitra Inc is an early-stage clinical biopharmaceutical company focused on developing therapies for precision dermatology using engineered proteins and live biotherapeutic products. Its discovery platform is screened for naturally occurring bacterial cells with beneficial effects. These microbes are then genomically sequenced and engineered to make cellular therapies, recombinant therapeutic proteins, peptides, and small molecules for the precision treatment of dermatology diseases. The company's product candidates include ATR-12, for treating the orphan disease and Netherton syndrome; ATR-04, a genetically modified strain of S. epidermidis for treating the papulopustular rash; and ATR-01, a potential treatment for ichthyosis vulgaris, a chronic, abnormally dry, scaly skin disease.
Azitra Inc has a market capitalization of $10.5 million. The company operates in the PHARMACEUTICAL PREPARATIONS industry classification. AZTR is listed on the XASE exchange. The company employs approximately 13 people. Azitra Inc is headquartered in BRANFORD, CT. The recorded listing date is 2023-06-16.
On this page you can find market AZTR stock price data, interactive price charts with multiple timeframes (1 day to max history), company financials including income statements, balance sheets, and cash flow statements, technical indicators (SMA 50, SMA 200, EMA 20, MACD, RSI), latest news and sentiment analysis, dividend history, stock splits, short interest data, float information, and related stocks.
Explore more: View today's market movers, use the stock screener, or browse all sectors. See more stocks in the PHARMACEUTICAL PREPARATIONS sector.